Dr Peter Kwong | Chief, Structural Biology Section

Dr Peter Kwong, Chief, Structural Biology Section, NIH

Dr. Kwong is Chief of the Structural Biology Section at the Vaccine Research Center at the National Institutes of Health.  He is internationally recognized for his work defining structural aspects of the HIV-1 envelope glycoproteins and their interactions with antibodies.  For the last several years, his efforts have focused on applying the atomic-level tools of structural biology to the development of effective vaccines against HIV-1 and other viral pathogens.


DC Pre-congress WS day April 2 @ 09:00

Workshop A: Advances in using structure-based knowledge for smarter vaccine designs

Structure-based vaccines are designed on the rationale that atomic-level information on antibody-antigen interactions can provide critical insight to assist the development of immunogens capable of inducing protection against pathogens. Structure-based vaccines have become a much-anticipated field over the years with increasingly more preclinical and clinical staged developments. This workshop focuses on recent advances and their application in providing protection against infectious diseases.
  • Progress in Stabilized Pre-fusion Glycoprotein Vaccines for Paramyxoviruses & HIV-1
  • Structure-based antigen design to tackle vaccine challenges for class I fusion proteins
  • Using structural based vaccine design to target flavivirus infections: Zika and Dengue
  • GSK’s CMV structural biology research
​Followed by Discussion with all speakers

back to speakers